|Min SIP Amount||₹500|
|NAV||₹113.73 (02 Jun 2020)|
|Fund Started||09 Aug 2004|
|Fund Size||₹5,367 Cr|
|Ipca Laboratories Ltd.||Healthcare||Equity||3.6%|
|Bayer CropScience Ltd.||Healthcare||Equity||3.4%|
|Abbott India Ltd.||Healthcare||Equity||3.2%|
|Aarti Industries Ltd.||Chemicals||Equity||2.6%|
|Shree Cement Ltd.||Construction||Equity||2.6%|
|Berger Paints India Ltd.||Chemicals||Equity||2.3%|
|Tata Consumer Products Ltd.||FMCG||Equity||2.2%|
|Coromandel International Ltd.||Chemicals||Equity||2.0%|
|Manappuram Finance Ltd.||Financial||Equity||2.0%|
L&T Midcap Fund Growth is a Equity Mutual Fund Scheme launched by L&T Mutual Fund. This scheme was made available to investors on 09 Aug 2004. Soumendra Nath Lahiri, Vihang Naik is the Current Fund Manager of L&T Midcap Fund Growth fund.The fund currently has an Asset Under Management(AUM) of ₹5,367 Cr and the Latest NAV as of 02 Jun 2020 is ₹113.73.
The L&T Midcap Fund Growth is rated High risk. Minimum SIP Investment is set to 500. Minimum Lumpsum Investment is 5000. For units in excess of 10% of the investment, 1% will be charged for redemption within 1 year.